跳至主要内容
临床试验/NCT03218436
NCT03218436已完成不适用

Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
63
试验地点
2
主要终点
Pathological remission of cervical intraepithelial neoplasia

研究概览

简要总结

Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort.

Primary endpoint after 3-6 months: Pathological remission.

Secondary endpoint: HPV remission.

详细描述

The study was completed with Less recruitment as it was planned due to overwhelming study success. The study was published in August 2023. A link has been added to the Reference section.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Histologically confirmed CIN III
  • Not fully visible transformation zone
  • An indication of invasive disease
  • Expected lack of compliance of the patient or incapacity of the patient to understand the meaning and purpose of the clinical trial
  • Severe cardio-vascular disease
  • Lack of patient consent

结局指标

主要结局

Pathological remission of cervical intraepithelial neoplasia

时间窗: 3-6 months

Biopsy, Histopathological examination

次要结局

  • Human papilloma virus remission rate(3-6 months)
  • Comfort / Dyscomfort during intervention(Immediately, 2 week, 3-6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验